Suzhou Lixin Pharmaceutical Co., Ltd. specializes in manufacturing Active Pharmaceutical Ingredients (APIs) and High-added-value intermediates. In pursuit of regulated API market in and out of China since its establishment, we have built GMP certificated workshops, Chemical Synthesis Workshops, facilities, and established standard quality management system and advanced quality control profile. Oriented at international market of APIs and intermediate materials, we have built strong co-operation with domestic and international pharmaceutical companies. With the innovation of production process and patent protection, it already has series of APIs including anti-tumor drugs, and cardiovascular drugs. In order to obtain favorable comments from customers on our high-quality products and standard quality management system, Lixin insists on studying the process and product quality under the guidelines of ICH and the rules of SFDA.
We posses a team of chemical scientists and managers engaged in the pharmaceutical industry. We also specialize in new products research, development, technology improvement, quality control, quality management, product sales and service.
Active Pharmaceutical Ingredients | Idebenone | Hydrochlorothiazide | Clopidogrel Bisulfate |
